Resource Center
Resource Center
Pilot program in West Bengal, India, demonstrates that the triple elimination of HIV, syphilis, and hepatitis B in pregnant women is possible
Read more
An alternative, more affordable hepatitis C treatment drugs cures 75% of patients who failed initial treatment in Rwanda
Read more
The CHAI 2023 Annual Report highlights our key roles as operational and strategic partners to governments, market shapers, and ecosystem catalysts within the global health space
Read more
Highlights from meetings CHAI participated in and resolutions passed at the recently concluded 77th World Health Assembly
Read more
This is the current list of sessions that CHAI is participating in at the World Hepatitis Summit, which will take place in Lisbon, Portugal, from April 9 to 11, 2024.
Read more
CHAI's 2022 Annual Report is out now, commemorating 20 Years of Saving Lives.
Read more
The 2023 CHAI Hepatitis C Market Intelligence Report with preliminary insights on harm reduction commodities provides market intelligence on hepatitis C (HCV) diagnostics and drugs in high-burden and low- and middle-income countries
Read more
CHAI is paving the way for an integrated screening approach for HIV, syphilis, and hepatitis B
Read more
Viral hepatitis treatment is more affordable than ever, but countries still need more resources for elimination
Read more
CHAI and The Hepatitis Fund have announced two new MOUs to dramatically lower the price of WHO-prequalified hepatitis C and B drugs in low- and middle-income countries.
Read more